Accel eyes stake in India’s Truemeds at $330 million valuation

[ad_1]

According to half a dozen sources, Accel, the global venture firm, is in advanced discussions to lead a funding round of $30 million to $40 million in Truemeds, an Indian online pharmacy that’s focused on providing customers with more affordable generic alternatives to costly branded medications.

[ad_2]

Source link